A stock image of a scientist wearing blue gloves and mask placing a tick in a test tube using tweezers.

...

Lucy Notarantonio

By Lucy Notarantonio

Senior Reporter

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


A new approach to fighting Lyme disease could one day be as easy as buying a bag of garden pellets from a home improvement store.

Researchers at The University of Texas at San Antonio (UTSA) are developing a non-toxic biologic designed to reduce the spread of Lyme disease before it reaches people or pets. Rather than focusing on treating humans, the team is targeting the small wild animals that help spread the bacteria to ticks in the first place.

The product could eventually be sold in big-box and home improvement stores, offering homeowners a new way to protect their yards from the country's most common tick-borne illness.

Read More on Wellness & Fitness

Dr Penelope Sheehan, a general practitioner, who was not involved in the study, told Newsweek: “It is a clever strategy because it tackles Lyme disease at its source by reducing how much bacteria the small mammals carry, rather than relying solely on people protecting themselves.

A stock image of a scientist wearing blue gloves and mask placing a tick in a test tube using tweezers.

...

She said: “It should therefore be seen as an additional layer of protection rather than a replacement for the usual precautions when spending time in the countryside.”

Tackling Lyme Disease at the Source

The project is led by Janakiram Seshu, a professor in UTSA's Department of Molecular Microbiology and Immunology.

Instead of vaccinating people or dogs, the researchers are focusing on so-called "reservoir hosts"—small animals such as squirrels, chipmunks and white-footed mice that naturally carry the bacteria responsible for Lyme disease. Ticks pick up the bacteria when they feed on these animals and can then pass it to humans or other animals through bites.

"Our entire philosophy is to prevent these small mammals running in the wild from having these pathogens so that they don't have a chance of transmitting them via ticks to humans or dogs," Seshu said in a statement.

According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 476,000 people may be diagnosed with and treated for Lyme disease in the United States each year.

Symptoms can vary, and some complications, including arthritis, can continue long after treatment and significantly affect quality of life.

Sheehan noted that ticks can carry several diseases beyond Lyme disease, warning that people should not let their guard down.

She said the best way to reduce the risk of infection remains using insect repellent, covering up in long grass and woodland, checking people and pets for ticks after spending time outdoors, and removing any attached ticks promptly.

How the Treatment Works

The scientists focused on Borrelia burgdorferi, the bacterium that causes Lyme disease.

The team identified proteins on the surface of the bacteria that help them survive inside host animals. They then developed what they describe as "pathogen-derived biologics"—essentially oral vaccines—that trigger an immune response in those animals.

Once the immune system responds, the amount of Lyme-causing bacteria in the animals drops dramatically, making it much harder for ticks to pick up the infection.

"We identified that these lipoprotein-based vaccines are highly effective in reducing the bacterial burden both in ticks as well as in the mammals," Venkatesh Kumaresan, an assistant professor of research in the Department of Molecular Microbiology and Immunology, said in a statement.

From the Lab to Backyards

The first version of the product is expected to come in the form of treated bait pellets that homeowners could place around yards and gardens.

Small mammals eat the pellets, and the biologic then works to reduce the amount of Lyme-causing bacteria in their bodies.

This could have a major effect on transmission. Tick larvae are born without the Lyme disease pathogen. When they feed on infected animals, they can acquire the bacteria and later spread it.

In preclinical trials, researchers found that bacterial levels in host animals fell from about 100,000 to nearly 100 after treatment. With far fewer bacteria available, ticks feeding on those animals picked up significantly less infection—or none at all.

The researchers say this could help break the cycle of transmission that leads to human infections.

Looking Beyond Lyme Disease

While the first product is focused on Lyme disease, the researchers are already exploring ways to expand the technology.

"Now we know that in addition to Lyme disease, there are up to seven pathogens that ticks can transmit," Seshu noted in a statement.

Future versions of the pellets are being designed to target multiple tick-borne pathogens at the same time. The goal is to create a broader layer of protection in residential environments, reducing the risk posed by ticks carrying a range of diseases.

If successful, the approach could shift Lyme disease prevention away from individuals and toward the environment itself, tackling the infection before ticks have a chance to spread it.

Contact Newsweek editors on this story: Kara Dolman and Gray R. Thomas

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines